SilverBox Corp IV announced that its units, Class A ordinary shares, and warrants have been delisted from the New York Stock Exchange effective September 28, 2026. The securities have transitioned to the OTCID Basic Market and are now trading under the new ticker symbols SBXUF, SBXDF, and SBXWF, respectively.
Hain Celestial Group Nasdaq/NYSE Compliance Notice
Hain Celestial received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, extending the deadline to March 22, 2027. To facilitate this, the company transferred its listing from The Nasdaq Global Select Market to The Nasdaq Capital Market. Separately, the company announced that Chief Accounting Officer Michael J. Ragusa will resign effective November 1, 2026.
Gossamer Bio has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share, resolving a deficiency notice originally received on April 8, 2026. The company achieved compliance following a 1-for-80 reverse stock split that became effective on September 10, 2026, and the matter is now closed.
Southland Holdings received a deficiency notice from NYSE American for failing to meet stockholders' equity requirements, reporting a deficit of $248.2 million as of June 30, 2026. The company has until October 23, 2026, to submit a compliance plan and until March 23, 2028, to regain compliance with the exchange's listing standards. The company's common stock and warrants will continue to trade on the NYSE American during the plan period.
Dyadic International Nasdaq/NYSE Compliance Notice
Dyadic International received two deficiency notices from Nasdaq for failing to maintain a minimum bid price of $1.00 per share and a minimum Market Value of Listed Securities (MVLS) of $35 million for 30 consecutive business days. The company has 180 calendar days, until March 24, 2027, to regain compliance with both requirements.
Fusemachines Inc. received a delisting notice from Nasdaq on September 24, 2026, after failing to regain compliance with the $50 million minimum Market Value of Listed Securities (MVLS) requirement by the September 23 deadline. The company intends to request a hearing before the Nasdaq Hearings Panel to stay the delisting and seek an extension to regain compliance. Trading of the company's common stock (FUSE) and warrants (FUSEW) will continue on Nasdaq pending the outcome of the hearing.
SilverBox Corp IV received a notice from the NYSE indicating that the exchange has commenced proceedings to delist the company's units, Class A ordinary shares, and warrants. The delisting determination was made because the company's average aggregate global market capitalization fell below the $40 million minimum requirement over a 30-day period. Trading on the NYSE has been suspended, and the securities are expected to begin trading on the over-the-counter (OTC) market on September 28, 2026.
Calidi Biotherapeutics received a deficiency notice from NYSE American for failing to maintain the minimum stockholders' equity requirement of $4.0 million. The company reported stockholders' equity of $3.1 million as of June 30, 2026, and has until October 21, 2026, to submit a plan to regain compliance by March 21, 2028.
Future Money Acquisition Corporation received a deficiency notice from Nasdaq on September 22, 2026, for failing to timely file its Form 10-Q for the quarter ended July 31, 2026. The company has 60 days to submit a plan to regain compliance and could be granted an extension until March 22, 2027, to file the delinquent report.
Netcapital Inc. received a deficiency notice from Nasdaq on September 21, 2026, for failing to timely file its Quarterly Report on Form 10-Q and its Annual Report on Form 10-K. The company has until October 23, 2026, to submit a plan to regain compliance, which if accepted, could grant an extension until February 9, 2027. The notice has no immediate effect on the listing of the company's common stock (NCPL).
SANUWAVE Health received a deficiency notice from Nasdaq because its Market Value of Listed Securities (MVLS) fell below the $50 million minimum requirement for 30 consecutive business days. The company has 180 calendar days, or until March 22, 2027, to regain compliance by maintaining an MVLS of at least $50 million for 10 consecutive business days.
Lumen Technologies is voluntarily transferring its stock exchange listing from the New York Stock Exchange (NYSE) to The Nasdaq Stock Market LLC. The common stock (LUMN) and two series of notes are expected to begin trading on Nasdaq on October 6, 2026, following their delisting from the NYSE on October 5, 2026.
Beasley Broadcast Group Nasdaq/NYSE Compliance Notice
Beasley Broadcast Group received a notice of non-compliance from Nasdaq following the passing of director Peter A. Bordes, Jr., which reduced the Audit Committee to two members. The company is required to have at least three independent directors on the committee and intends to appoint a replacement within the provided cure period ending no later than September 19, 2027.
SCWorx Corp. received a delisting decision from the Nasdaq Hearings Panel on September 17, 2026, due to a deficiency in publicly held shares following a reverse stock split. The company has requested reconsideration of the decision, claiming it cured the deficiency by issuing 449,860 shares in a private placement on September 16. To regain compliance, the company must also maintain a minimum bid price of $1.00 for 10 consecutive days by October 5, 2026.
Aditxt, Inc. received notice that Nasdaq will file a Form 25 with the SEC to formally complete the delisting of its common stock, following a suspension of trading that began on June 25, 2026. The delisting will become effective ten days after the filing, and the company's common stock currently trades on the OTC Market.
Greenland Technologies Holding Corporation has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The company's Class A ordinary shares maintained a closing bid price of at least $1.00 for 10 consecutive business days from September 8 to September 21, 2026. Nasdaq has officially closed the matter, resolving the deficiency notice originally issued in March 2026.
Lakeshore Acquisition III Nasdaq/NYSE Compliance Notice
Lakeshore Acquisition III Corp. received approval from Nasdaq to transfer the listing of its units, ordinary shares, and rights from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer is effective at the opening of business on September 24, 2026, and the securities will continue to trade under their existing symbols (LCCCU, LCCC, and LCCCR).
CytoSorbents has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its stock closed at or above that level for 10 consecutive trading sessions. However, the company remains non-compliant with the $35 million Minimum Market Value of Listed Securities (MVLS) requirement and has until December 28, 2026, to resolve this deficiency.
Reborn Coffee received a deficiency notice from Nasdaq on September 16, 2026, for failing to meet the minimum stockholders' equity requirement of $2.5 million, reporting only $735,642 in its latest quarterly filing. The company has until November 2, 2026, to submit a plan to regain compliance, which could lead to a 180-day extension if accepted. Separately, Nasdaq confirmed the company regained compliance regarding its periodic filing requirements after the late 10-Q was submitted.
BioCardia has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its common stock closed at or above $1.00 per share for at least 10 consecutive business days. The company had previously received a deficiency notice on August 19, 2026, and Nasdaq has now officially closed the matter. The company's common stock will continue to trade on The Nasdaq Capital Market under the symbol 'BCDA'.
Linkhome Holdings Inc. has regained compliance with Nasdaq's minimum bid price requirement after its common stock maintained a closing bid price of at least $1.00 per share for 10 consecutive business days. The company had previously received a deficiency notice on June 29, 2026, for failing to meet the $1.00 threshold. Nasdaq has officially closed the matter, ensuring the company's continued listing on the Nasdaq Capital Market.
InMed Pharmaceuticals received a deficiency notice from Nasdaq for failing to maintain the minimum $2.5 million shareholders' equity requirement for continued listing. The company reported shareholders' equity of $1,075,007, largely due to expenses related to its pending merger with Mentari Therapeutics. InMed expects to regain compliance upon the closing of the merger, which is anticipated to bring approximately $490 million in gross proceeds to the combined company.
Moleculin Biotech received a Staff Determination Letter from Nasdaq notifying the company that its common stock failed to maintain the $1.00 minimum bid price for 30 consecutive business days. Because the company already performed a reverse stock split within the last year, it is ineligible for the standard 180-day grace period and faces immediate delisting unless it successfully appeals to the Nasdaq Hearings Panel.
Fusemachines Inc. received a deficiency notice from Nasdaq on September 18, 2026, because its common stock closing bid price remained below $1.00 for 30 consecutive business days. The company has 180 calendar days, or until March 17, 2027, to regain compliance by maintaining a bid price of at least $1.00 for 10 consecutive business days.
BeyondSpring Inc. received a deficiency notice from Nasdaq on September 17, 2026, because its ordinary shares closed below the $1.00 minimum bid price for 30 consecutive business days. The company has 180 calendar days, or until March 16, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days.
Filana Therapeutics received a deficiency notice from Nasdaq on September 17, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 calendar days, until March 16, 2027, to regain compliance by having its stock close at or above $1.00 for at least 10 consecutive business days.
Hyperfine, Inc. received a deficiency notice from Nasdaq on September 17, 2026, because its Class A common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive business days. The company has until March 16, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. If compliance is not met, the company may be eligible for an additional 180-day period if it transfers to The Nasdaq Capital Market and meets other listing standards.
NextNRG, Inc. received a delisting notice from Nasdaq on September 15, 2026, after failing to regain compliance with the $1.00 minimum bid price requirement by the compliance deadline. Nasdaq also determined the company was ineligible for a second 180-day grace period due to insufficient stockholders' equity. The company intends to appeal the decision before the Nasdaq Hearings Panel, which will stay the delisting process while the appeal is pending.
TELA Bio received a delisting notice from Nasdaq on September 15, 2026, after failing to regain compliance with the $1.00 minimum bid price requirement during its 180-day grace period. The company intends to request a hearing before a Nasdaq Hearings Panel to stay the delisting and present a compliance plan, which includes a proposed reverse stock split. Trading of the company's common stock will continue on the Nasdaq Global Market pending the conclusion of the hearing process.
Stardust Power Inc. received a deficiency notice from Nasdaq on September 11, 2026, because its common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has until March 10, 2027, to regain compliance, which may involve the stock price closing at or above $1.00 for at least ten consecutive business days or implementing a reverse stock split.